Shares of healthcare solutions provider Solventum (NYSE:SOLV) jumped 5% in the afternoon session after the company reported third-quarter 2026 financial results and raised its full-year adjusted earnings per share guidance.
Tipranks Press Release.
Solventum (NYSE:SOLV) reports that more than 90% of its separation from former parent 3M is now complete. The healthcare supplier has executed its largest ever ERP cutover, consolidating core systems into a new standalone platform. Management has renegotiated a raw material supply agreement with 3M and plans to separate the Health Information Systems business for clearer focus. The ERP cutover, 3M separation progress and planned Health Information Systems carve out only tell part of the...
Solventum (SOLV) delivered earnings and revenue surprises of +7.41% and -1.07%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
SOLV's strong Q2 performance, growth investments and cost-saving program support its outlook, though higher raw material costs remain a concern.
Solventum's Q3 results are likely to face ERP-related order reversals and tariff pressures, while MedSurg, Dental and Acera growth may have supported underlying performance.
SOLV's strong Q2 performance, growth investments and cost-saving program support its outlook, though higher raw material costs remain a concern.
Earlier this quarter, Solventum reported results that surpassed analyst expectations, with both organic revenue and EPS beating estimates and management emphasizing strong execution and ongoing transformation efforts. An interesting angle is how Solventum’s exposure to surgical equipment and consumables, including AI and robotics-enabled solutions, supports relatively consistent procedural demand and innovation-driven opportunities. Now we’ll explore how this stronger-than-expected quarter,...
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at surgical equipment & consumables - diversified stocks, starting with Solventum (NYSE:SOLV).
This is the newest page. Registered accounts read further back.